glp 1 agonist trials Lilly orforglipron oral GLP-1 phase 3 weight loss trial Dual GIP/GLP-1 receptor agonists: New

Although efforts by the academic community to explore ADC resistance in autoimmune diseases are noticeable overall, we must still recognize that related research remains considerably insufficient

Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet

Older persons with these tattoos may not be able to recall the event

Despite its promise, further research is needed to fully understand hepsin's mechanisms of action and safety profile

Additionally, miRNA-223 exhibits anti-fibrotic properties by downregulating the expression of GLI2 and PDGF receptors (PDGFR and PDGFR) in HSCs, reducing their activation ( Figure 4D )